STEPHEN SKIMEHORN: Open Payments
NPI 1326360355 · TILTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 35 payments from 10 companies in 2025. Trend: 2023 $168 · 2024 $430 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $137 |
| AstraZeneca Pharmaceuticals LP | 4 | $100 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Janssen Pharmaceuticals, Inc | 3 | $60 |
| Lilly USA, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, BREZTRI, AUSTEDO XR, INVEGA SUSTENNA, MOUNJARO, ABILIFY ASIMTUFII, REXULTI.
Industry payments across IL — which companies pay providers there.
